The Wang Lab studies neurodegeneration and cell death induced by brain injury, mitochondrial dysfunction, and/or genome instability.

The Harbour Lab uses genomic technologies and genetically engineered human cells and mouse models to develop biomarkers and elucidate mechanisms of tumor evolution and metastasis in uveal melanoma and retinoblastoma.

The De Brabander Lab focuses on the synthesis of complex molecular architectures, including both designed and naturally occurring substances with novel structural features and interesting biological function. 

The Davis Lab is part of the Section of Molecular Medicine in the Department of Radiation Oncology

Our mission is to improve the care of breast cancer patients through cutting-edge translational research at the interface of clinical oncology, cancer biology, molecular genetics, and translational genomics.

Our mission is to innovate, develop, and apply biomedical technology to empower cancer research.

Medical Artificial Intelligence and Automation

The Luo lab studies hypoxia stress in human cancers with a focus on epigenetic and metabolic alterations. 

We are working at the interface of nanotechnology, drug delivery, and tumor immunology

Our lab currently studies hypoxia, prolyl hydroxylase, and VHL signaling in cancer, especially breast and renal cell carcinomas.